245
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Small Intestinal Bacterial Overgrowth in Patients with Gallbladder Polyps: A Cross-Sectional Study

, , &
Pages 813-822 | Received 06 Dec 2022, Accepted 01 Feb 2023, Published online: 01 Mar 2023

References

  • McCain RS, Diamond A, Jones C, et al. Current practices and future prospects for the management of gallbladder polyps: a topical review. World J Gastroenterol. 2018;24(26):2844–2852.
  • Gautam A, Pandey A, Masood S, et al. Incidental gallbladder carcinoma in gallbladder polyps: challenges of gallbladder malignancy for an endemic population. Malays J Med Sci. 2021;28(1):27–34.
  • Wiles R, Thoeni RF, Barbu ST, et al. Management and follow-up of gallbladder polyps: joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery - European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE). Eur Radiol. 2017;27(9):3856–3866.
  • Foley KG, Lahaye MJ, Thoeni RF, et al. Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE. Eur Radiol. 2021;2021:1.
  • Babu BI, Dennison AR, Garcea G. Management and diagnosis of gallbladder polyps: a systematic review. Langenbecks Arch Surg. 2015;400(4):455–462.
  • Lu D, Radin R, Yung E, et al. Malignant transformation of a 5-mm gallbladder polyp over 2 years: a case report and review of current literature. Ultrasound Q. 2015;31(1):66–68.
  • Lin WR, Lin DY, Tai DI, et al. Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases. J Gastroenterol Hepatol. 2008;23(6):965–969.
  • Xu Q, Tao LY, Wu Q, et al. Prevalences of and risk factors for biliary stones and gallbladder polyps in a large Chinese population. HPB. 2012;14(6):373–381.
  • Ahn DW, Jeong JB, Kang J, et al. Fatty liver is an independent risk factor for gallbladder polyps. World J Gastroenterol. 2020;26(44):6979–6992.
  • Yamin Z, Xuesong B, Guibin Y, et al. Risk factors of gallbladder polyps formation in East Asian population: a meta-analysis and systematic review. Asian J Surg. 2020;43(1):52–59.
  • Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361(9356):512–519.
  • Ghoshal UC, Baba CS, Ghoshal U, et al. Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture. Indian J Gastroenterol. 2017;36(5):390–399.
  • Ghoshal UC, Shukla R, Ghoshal U. Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy. Gut Liver. 2017;11(2):196–208.
  • Pimentel M, Saad RJ, Long MD, et al. ACG clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. 2020;115(2):165–178.
  • Grundy SM. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421.
  • Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus. Am J Gastroenterol. 2017;112(5):775–784.
  • Farrell GC, Chitturi S, Lau GK, et al. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007;22(6):775–777.
  • Lema I, Araujo JR, Rolhion N, et al. Jejunum: the understudied meeting place of dietary lipids and the microbiota. Biochimie. 2020;178:124–136.
  • Miazga A, Osinski M, Cichy W, et al. Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO. Adv Med Sci. 2015;60(1):118–124.
  • Singla R, Dutta U, Aggarwal N, et al. Vitamin-D deficiency is associated with gallbladder stasis among pregnant women. Dig Dis Sci. 2015;60(9):2793–2799.
  • Wu L, Wang Y, Zhu S, et al. Changes in plasma bile acids are associated with gallbladder stones and polyps. BMC Gastroenterol. 2020;20(1):363.
  • Bolt MJ, Stellaard F, Sitrin MD, et al. Serum unconjugated bile acids in patients with small bowel bacterial overgrowth. Clin Chim Acta. 1989;181(1):87–101.
  • Bala L, Ghoshal UC, Ghoshal U, et al. Malabsorption syndrome with and without small intestinal bacterial overgrowth: a study on upper-gut aspirate using 1H NMR spectroscopy. Magn Reson Med. 2006;56(4):738–744.
  • Roland BC, Lee D, Miller LS, et al. Obesity increases the risk of small intestinal bacterial overgrowth (SIBO). Neurogastroenterol Motil. 2018;30(3):154.
  • Mushref MA, Srinivasan S. Effect of high fat-diet and obesity on gastrointestinal motility. Ann Transl Med. 2013;1(2):14.
  • Lim SH, Kim D, Kang JH, et al. Hepatic fat, not visceral fat, is associated with gallbladder polyps: a study of 2643 healthy subjects. J Gastroenterol Hepatol. 2015;30(4):767–774.
  • Wijarnpreecha K, Lou S, Watthanasuntorn K, et al. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2020;32(5):601–608.
  • Kanda T, Goto T, Hirotsu Y, et al. Molecular mechanisms: connections between nonalcoholic fatty liver disease, steatohepatitis and hepatocellular carcinoma. Int J Mol Sci. 2020;21(4):57.
  • Kapil S, Duseja A, Sharma BK, et al. Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2016;31(1):213–221.
  • Vanni E, Bugianesi E. The gut-liver axis in nonalcoholic fatty liver disease: another pathway to insulin resistance? Hepatology. 2009;49(6):1790–1792.
  • Park EJ, Lee HS, Lee SH, et al. Association between metabolic syndrome and gallbladder polyps in healthy Korean adults. J Korean Med Sci. 2013;28(6):876–880.
  • Choi YS, Do JH, Seo SW, et al. Prevalence and risk factors of gallbladder polypoid lesions in a healthy population. Yonsei Med J. 2016;57(6):1370–1375.
  • Remely M, Aumueller E, Jahn D, et al. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity. Benef Microbes. 2014;5(1):33–43.
  • Fialho A, Fialho A, Thota P, et al. Higher visceral to subcutaneous fat ratio is associated with small intestinal bacterial overgrowth. Nutr Metab Cardiovasc Dis. 2016;26(9):773–777.
  • Yang HL, Kong L, Hou LL, et al. Analysis of risk factors for polypoid lesions of gallbladder among health examinees. World J Gastroenterol. 2012;18(23):3015–3019.
  • Yamin Z, Xuesong B, Zhen Z, et al. Correlation of dyslipidemias and gallbladder polyps-A large retrospective study among Chinese population. Asian J Surg. 2020;43(1):181–185.
  • Shinkai H, Kimura W, Muto T. Surgical indications for small polypoid lesions of the gallbladder. Am J Surg. 1998;175(2):114–117.
  • Yeh CN, Jan YY, Chao TC, et al. Laparoscopic cholecystectomy for polypoid lesions of the gallbladder: a clinicopathologic study. Surg Laparosc Endosc Percutan Tech. 2001;11(3):176–181.
  • Kwon W, Jang JY, Lee SE, et al. Clinicopathologic features of polypoid lesions of the gallbladder and risk factors of gallbladder cancer. J Korean Med Sci. 2009;24(3):481–487.
  • Terzioglu SG, Kilic MO, Sapmaz A, et al. Predictive factors of neoplastic gallbladder polyps: outcomes of 278 patients. Turk J Gastroenterol. 2017;28(3):202–206.